share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GUYER DAVID R

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GUYER DAVID R

EyePoint Pharmaceuticals | 4:持股變動聲明-董事 GUYER DAVID R
美股SEC公告 ·  07/17 04:28
牛牛AI助理已提取核心訊息
On July 12, 2024, David R. Guyer, associated with EyePoint Pharmaceuticals, Inc. [EYPT], completed a series of transactions involving the company's common stock. Guyer acquired a total of 9,775 shares through the exercise or conversion of derivative securities at prices ranging from $3.26 to $3.50 per share. Subsequently, Guyer sold 11,625 shares on the open market at a price of $10.0641 per share. Following these transactions, Guyer's direct holdings in EyePoint Pharmaceuticals decreased to 1,850 shares. The total market value of the disposed shares amounted to approximately $116,995.16.
On July 12, 2024, David R. Guyer, associated with EyePoint Pharmaceuticals, Inc. [EYPT], completed a series of transactions involving the company's common stock. Guyer acquired a total of 9,775 shares through the exercise or conversion of derivative securities at prices ranging from $3.26 to $3.50 per share. Subsequently, Guyer sold 11,625 shares on the open market at a price of $10.0641 per share. Following these transactions, Guyer's direct holdings in EyePoint Pharmaceuticals decreased to 1,850 shares. The total market value of the disposed shares amounted to approximately $116,995.16.
2024年7月12日,與eyepoint pharmaceuticals有關的David R.Guyer完成了一系列與該公司普通股有關的交易。Guyer通過行權或轉換衍生證券以每股3.26美元至3.50美元的價格獲取了總共9,775股。隨後,Guyer以每股10.0641美元的價格在公開市場上出售了11,625股。經過這些交易後,Guyer在EyePoint Pharmaceuticals的直接持股減少到1,850股。出售的股份的總市值約爲116,995.16美元。
2024年7月12日,與eyepoint pharmaceuticals有關的David R.Guyer完成了一系列與該公司普通股有關的交易。Guyer通過行權或轉換衍生證券以每股3.26美元至3.50美元的價格獲取了總共9,775股。隨後,Guyer以每股10.0641美元的價格在公開市場上出售了11,625股。經過這些交易後,Guyer在EyePoint Pharmaceuticals的直接持股減少到1,850股。出售的股份的總市值約爲116,995.16美元。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。